Stefanie Koristka

Company: Intellia Therapeutics

Job title: Principal Scientist

Seminars:

Synthetic Tregs for Treatment of Colitis 2:00 pm

• Describe the synthetic Treg (synTreg) platform (Tregs produced from CD4 T-cells) • Present efficacy data of synTregs in xeno-GvHD, mouse colitis, and humanized colitis models NEW DATARead more

day: Day Two Track A, PM